According to Mary Kay inventors, sensitive skin has a tendency toward dryness or flaking and flushing, reddening or blushing (i.e., erythema) when exposed to stimuli such as UV light, heat, cold, chemicals or even active ingredients in skin formulas.
Indeed, some actives known to cause erythema in sensitive skin are used to treat fine lines and wrinkles, sagging skin, acne, etc. As such, individuals affected by sensitive skin either must avoid such products or apply products that can help to alleviate these symptoms.
Market Need
This invention relates to a combination of ingredients that can be used to treat or prevent erythema (i.e., reddened/flushed skin) in sensitive skin. This combination can be included in a wide range of product formulations, such as toners, gels, masks, etc.
The Literature
Compositions for sensitive skin
U.S. Patent 10736837
Publication date: Aug. 11, 2020
Assignee: Mary Kay Inc.
Specifically disclosed herein are compositions that include a combination of hydrolyzed algin, escin, Ruscus aculeatus (butcher's broom) root extract, ammonium glycyrrhizate, Centella asiatica extract, hydrolyzed yeast protein and Calendula officinalis flower extract. Also described is a method for treating dry, flaky skin by topically applying the composition to reduce dryness, flakiness or combinations thereof.
This combination can be used in a variety of product formulations (e.g., toners, cleansers, emulsions such as lotions or creams, masks, gels, etc.) along with antioxidants and other active ingredients known to cause erythema when applied to sensitive skin.
Patent accessed on Oct. 6, 2020.
